Sunday, 23 January 2022

Australia's most trusted
source of pharma news

Sunday, 23 January 2022

Big names join MA as advisors

Posted 28 October 2021 AM

Two health industry heavyweights - CEO of Rare Cancers Australia Richard Vines and former Secretary of the Department of Health Glenys Beauchamp - have been recruited to join Medicines Australia's future-focused Advisory Council ahead of its next meeting in November. 

"It is with great pleasure to introduce these two brilliant minds to the Advisory Council," Chair of MA Board and Chair of the Advisory Council, Dr Anna Lavelle said.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.